Practical management of chronic fatigue syndrome or myalgic encephalomyelitis in childhood

Amberly Brigden1, Maria Loades1,2,3, Anna Abbott3

  • 1Centre for Child and Adolescent Heath, School of Social and Community Medicine, University of Bristol, Bristol, UK.

Insights

Paediatric chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) significantly impacts UK school children, causing disability. Effective treatments exist, but diagnosis and access remain challenging for affected youth.

Area of Science:

  • Pediatrics
  • Neurology
  • Immunology

Background:

  • Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) affects over 1% of UK secondary school children.
  • The condition is highly disabling, impacting daily life and education.
  • Current understanding of diagnosis and treatment in childhood remains limited.

Purpose of the Study:

  • To summarise current knowledge on diagnosing paediatric CFS/ME.
  • To review effective treatment strategies for children with CFS/ME.
  • To highlight barriers in diagnosis and treatment access for paediatric CFS/ME.

Main Methods:

  • Literature review of existing studies on paediatric CFS/ME diagnosis and treatment.
  • Synthesis of current clinical guidelines and research findings.
  • Analysis of epidemiological data on CFS/ME prevalence in children.

Main Results:

  • Paediatric CFS/ME affects a significant portion of secondary school children.
  • Effective treatments are available but underutilised due to diagnostic delays.
  • Barriers to care include lack of awareness and specialist services.

Conclusions:

  • Improved diagnostic pathways are crucial for timely intervention in paediatric CFS/ME.
  • Accessible and effective treatments can improve outcomes for affected children.
  • Further research and healthcare system adjustments are needed to support children with CFS/ME.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
588
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
435
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
297